US2009181922A1PendingUtilityA1

Palatinose for enhancing dietary supplement and pharmaceutical delivery

Individually held — no corporate assignee on recordPriority: Mar 20, 2006Filed: Mar 25, 2009Published: Jul 16, 2009
Est. expiryMar 20, 2026(expired)· nominal 20-yr term from priority
A61K 9/0019A61K 31/7016A61K 31/566A61K 31/197A61K 38/05A61K 45/06A61K 33/00A61K 31/70A61K 31/7076A61K 31/122
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.

Claims

exact text as granted — not AI-modified
1 . A dietary supplement comprising:
 palatinose or a derivative thereof;   a sugar;   a stimulant;   at least one amino acid or derivative thereof; and   at least one mineral.

Join the waitlist — get patent alerts

Track US2009181922A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.